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 ABSTRACT 
Doctors and Pharmacists play a foremost role in safe, effective use of medication in health care. Still, there is no 
database available through which Doctor can communicate with all field of pharmacy such as hospital Pharmacy, 
Clinical Pharmacy, Community Pharmacy, Nutrition Pharmacy and Drug research center so that they would like to 
cooperate with pharmacists in Medication error prevention, Drug-Disease management, Nutrition management, 
and pharmacotherapy. The authors examined the comprehensive project of implementing Electronic Drug 
Information Record (EDIR), introduce the new term Pharmacybernetic and how to reduce the medication error by 
integrated management system (IMS). This paper presented EDIR conceptual model and the flow sheet of the 
Pharmacybernetic system, which describes the integration of different Pharmaceutical related aspect in the field of 
Cybernetic. 
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1. INTRODUCTION 
Pharmacybernetic is the branch of cybernetic that deals with the study of control and communication of 
drug. Electronic Drug information record (EDIR) will create database that consist of all the information 
about Drug. This will help for the scientist for new drug development through which we can easily search 
of new drugs either from natural, semisynthetic or from synthetic source. It is also beneficial for drug 
modification having drug solubility, poor bioavailability and other physicochemical parameter. We can 
also integrate the information about different drugs interaction, drug food interaction, and toxicological 
data of different drugs, therapeutic drugs comparison and new drug combinations of already resistant 
diseases. Pharmacist can up-to-date his knowledge through electronic drug information record (EDIR).  
Physicians and Pharmacists play a major role in safe use of medication in primary outpatient care. Still, 
little is known about primary care physicians’ perceptions of medication errors and error prevention and 
how they would like to cooperate with pharmacists in error prevention and management [1]  
 
1.1 Mission of Pharmacybernetic: 
Pharmacybernetic is supposed to enable essential development to the EDIR. EDIR will considerably 
improve the process information containing collect, organize, extend, and utilize. Until now, the several 
of healthcare records were printed on paper [2]. The EDIR will help the data to reorganize and update and 
we can easily access by our computers or on mobiles.  The Pharmacybernetic open up inventive 
possibility while it allows various people to view the same record at the same time from different 
computers, also to improve the most updated information. 
 
 
1.2 Advantages of Pharmacybernetic: 
EDIR has a great acceptability and it is a secure procedure for saving information. It helps to see all 
pharmacological drug action and it source in one platform. It helps the Pharmacist to search new sources 
for treatment of diseases and also modify the already available drugs in the market. For the last thirty 
years, the enlargement and operation of computerized has been observing as a really hard task. Now, we 
are introducing EDIR which is supposed to permit enlarged uniformity and decreased redundancy of 
information [3]. The better use of this technology has allowed pharmacist, doctors, nurses, and clinical 
administrators to perform tasks faster and easier [4]. 
 
1.3 Problem Statement 
There are no integrated foundations of Drug information which contain not only the clinical parameters 
but also drug design of single drug. Number of new drugs is approved consistently by FDA but their 
record is not maintained electronically. There is no electronic record of poison of natural source or by 
chemical source. Doctors are not up-to-date with new medicine since they are using traditional medicine. 
Use of different drug guide by the pharmacist or doctor in emergency case is time taken and patient need 
immediate treatment. There are no records of the drugs that are obtained from several sources. It is not 
possible to remember the dose and drug interaction of all drugs. There is no communication between 
pharmacist and doctor through which doctor can express about the after-math of drugs and through which 
pharmacist can work on the drug to reduce its toxicity or to decrease it Adverse side effect. There is the 
big gap between researcher and Doctor. As a result patient will suffer. There are no mechanisms through 
which Pharmacist, Doctors and researcher will work on single platform to solve problem related drugs. 
 
1.4 Research Objective 
The purpose of this research is to propose a new model for Electronic Drug information record (EDIR) 
application. It will recommend a model to improve the Drug Information System (DIC). The Objective of 
this research is to ensure sufficient in-depth knowledge of the challenges that we are facing related to 
Drug database, particularly in the Drug research center (DRC) and how to develop EDIR infrastructure 
and the use of cybernetic in the field of Pharmacy. In this research the specific objectives are as follows: 
 
• To study detail understanding of electronic drug information record, different medication & 
Pharmaceutical Error and does detail literature review. 
 
• To propose a new electronic drug information record model, improve the Drug Information System 
(DIC) and Drug research center (DRC) 
 
• To integrate cybernetic in the field of Pharmacy. 
 
2. LITERATURE REVIEW 
Information and Communication Technology (ICT) has become the information resource of both range 
and prerequisite and has thus inspired from the boundary of healthcare. Swift developments in ICT with 
reduced costs, upgraded trustworthiness and better robustness are enabling a new wave of transform in 
how and where healthcare can be delivered. Many researchers consider that the electronic record will 
noticeably modify healthcare, rather than simply switching the Paper-based Record (PR). This 
modification permits data to be used for a extensive diversity of purposes ranging from direct patient care, 
decision maintain, quality promise, scientific research, and management of healthcare facilities [5]. The 
bio cybernetic loop [6] is the essential component of a physiological computing system. The loop 
functions as a conceptual entity derived from control theory [7] that also defines the flow of data within 
the system. From bio cybernetics, we amend this phenomenon in the arena of pharmacy and gives the 
term Pharmacybernetic. Pharmacybernetic is an upcoming zone of pharmacy which comprises highly 
advanced skills and expertise to deal with technologies in relation to medicines and drugs. The term 
‘pharma’ is derived from the Greek term ‘pharmakon’ meaning drugs or poisons [8], and ‘cybernetics’ 
comes from the Greek term ‘kubernetes’, which can be translated to mean ‘the art of steering’ [9]. The 
concept of ‘pharma-cybernetics’ is familiarized through the formation of an cooperative tool which 
consists of a pill-catching game and hangman game planned to assist users to learn about warfarin tablet 
strengths and drug interactions, based on user-centered (UCD), experience-centered (ECD), and activity-
centered design (ACD) approaches [10]. EDIR is an enormous record about drug chemistry, 
pharmacokinetic, pharmacodynamic, toxicological and clinical data and there are many efforts in the past 
to merge into single electronic database center which is beneficial not only for the pharmacist, doctor or 
researcher but also help to the humanity. A methodological review of a user-centered structure that 
integrates best practices in literacy, information quality, and human–computer interface design and 
evaluation to guide the design and redesign process of a consumer health website. Following the 
description of the methods, a case analysis is presented, demonstrating the successful application of the 
model in the redesign of a consumer health information website with call center. Assessments between 
the iterative revisions of the website showed improvements in usability, readability, and user satisfaction 
[11].  Stephanie Holmgren [12] had work in the Toxicology Data and Information Management .Yu 
HsuanYen [13] studied the comparison of  the efficiency and influence of an electronic ADE management 
system with a traditional working model at a medical center. Electronic health records (EHRs) have 
increased in popularity in many countries. Pushed by legal mandates, EHR systems have seen substantial 
progress recently, including increasing acceptance of standards, enhanced medical terminologies and 
improvements in technical infrastructure for data sharing across healthcare providers. Although the 
progress is directly helpful to patient care in a hospital or clinical setting, it can also support drug 
discovery. EHR is helpful in a drug discovery framework: finding novel relationships between diseases, 
re-evaluating drug usage and discovering phenotype–genotype associations. We believe that in the near 
future EHR systems and associated databases will effect considerably how we discover and develop safe 
and efficacious medicines [14]. The continually rising number of chemical compounds and 
uninterruptedly growing amount of data associated with them render it impossible to handle this 
information using the manual, traditional techniques that have been used for the last two hundred years of 
chemical sciences. With the birth of the computer it was undoubtedly accepted that the diversified data in 
chemistry could only be handled by electronic means. An impressive number of electronic sources are 
now available, and there is an almost bewildering number of versions and platforms (hosts, in-house 
systems, etc.) for major sources. Add to this the continuing changes in all the data collected, and this 
chapter can only provide an orientation and a starting point for further enquiries. T. Engel gives a flavor 
of the most essential databases used for drug discovery. Also, he focuses on chemical databases; sequence 
and other biological and biochemical databases are discussed in detail [15]. Clinical event monitors are a 
kind of lively medication monitoring system that can use signals to alert clinicians to possible adverse 
drug reactions. The primary goal was to estimate the positive predictive values of select signals used to 
systematize the detection of ADRs in the medical intensive care unit. [16] 
 
3. RESEARCH METHODOLOGY 
Electronic Drug Information Record (EDIR) diverges largely with lots of groups centering on the 
provider requirements for information management and information sharing. The basic purpose to 
integrate the pharmaceutical services is to provide better health care to the patient and to build stronger 
relationship between doctor and pharmacist. 
3.1. Purposed Model of Electronic Drug Information Record 
The technological adaptation of Pharmaceutical records is the need of the hour. So we develop a database 
that integrates the information of all kind of drug. As below in Figure 1 we have shown proposed 
Electronic Drug Information Record (EDIR).   
  
 Figure 1.   Electronic Drug Information Record 
 3.2. Flow sheet of cybernetic system 
Cybernetic system consist of integrated database providing data from different Health and pharmaceutical 
related field such as Public health record and Epidemic Drug record from the community pharmacy, Drug 
event monitoring in hospitals, Prescription and pharmaconutrotherapy record from the hospitals and 
clinics. We can collect the data from the patient in hospitals, clinics and community pharmacy. The 
record then reach to drug research center where it is collected in the drug database which can easily 
access to the doctors and pharmacist. 
 
 
Figure 2.   Flow sheet of Pharmacybernetic System 
All the record will enter into drug reach center and drug database. Drug research center will receive all 
the enquiry related to prescription, Drug event monitoring, nutritional consultancy and Epidemic Drug 
record and researcher work on new drug development, Drug Pharmacokinetic and Drug 
Pharmacodynamic parameter. This will help Pharmacist and doctor to identify medication error. 
 
4. CONCLUSIONS AND FINDING 
The outcome of this research is to recommend a new model that supports the Electronic Drug information 
record (EDIR) application. It will study indispensable related work to study the accessible Public health 
record, Drug event monitoring, Prescription Monitoring, Pharmaconutrotherapy and Epidemic Drug 
record. It will propose new model to improve the Drug Research Center. The objective of this research is 
to ensure satisfactory EDIR framework and integrate Cybernetic in the field of Pharmacy to meet future 
challenges 
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